Greenberg S B, Faerber E N, Aspinall C L, Adams R C
Department of Radiology, St. Christopher's Hospital, Philadelphia, PA 19134.
AJR Am J Roentgenol. 1993 Sep;161(3):639-41. doi: 10.2214/ajr.161.3.8352124.
Sedation is frequently essential for successful MR imaging, and chloral hydrate is the most commonly used drug for this purpose in infants and children. Our experience with these patients suggested that this sedative is less effective in older children, even when administered in high doses. However, no prospective study comparing the efficacy of chloral hydrate sedation for children of different ages undergoing MR imaging has been reported. Accordingly, we performed a study to evaluate the effectiveness and safety of chloral hydrate sedation in children of various ages.
The study included 300 infants and children, 1 month to 11 years old (mean, 3 years), who were given oral chloral hydrate, 100 mg/kg, for sedation before MR imaging. The maximum total dose administered was 2.5 g, which limited the study to children who weighed 25 kg or less. Sedation was considered successful when MR studies were completed and at least 95% of the images had little or no motion artifact.
Sedation was successful in 273 (91%) of 300 children. It was unsuccessful in nine of the 203 children who were 48 months old or younger (96% success rate) and in 18 of the 97 children who were more than 48 months old (81% success rate). A single-tailed t-test showed that the children in whom sedation was unsuccessful were significantly older than those in whom it was successful to the .0005 level of significance. The failure rate increased steadily for children more than 48 months old. Several failures may also have resulted from lengthy examination times. Adverse reactions to chloral hydrate sedation included hyperactivity (6%), vomiting (4%), and mild respiratory depression (4%). No adverse reaction was severe enough to require hospitalization.
The higher failure rate for chloral hydrate sedation in children more than 48 months old suggests that the patient's age is an important limitation to the usefulness of chloral hydrate sedation for children undergoing MR imaging. However, the low rate of adverse reactions makes chloral hydrate a safe drug for sedation of children undergoing MR imaging.
镇静对于成功进行磁共振成像(MR成像)常常至关重要,水合氯醛是婴幼儿和儿童中最常用于此目的的药物。我们对这些患者的经验表明,这种镇静剂在大龄儿童中效果较差,即便给予高剂量也是如此。然而,尚无前瞻性研究比较水合氯醛镇静对不同年龄接受MR成像儿童的疗效。因此,我们开展了一项研究以评估水合氯醛镇静在不同年龄段儿童中的有效性和安全性。
该研究纳入了300名1个月至11岁(平均3岁)的婴幼儿和儿童,他们在进行MR成像前口服100mg/kg水合氯醛以进行镇静。最大总给药剂量为2.5g,这将研究限制于体重25kg或以下的儿童。当MR检查完成且至少95%的图像几乎没有或没有运动伪影时,镇静被认为是成功的。
300名儿童中有273名(91%)镇静成功。在203名48个月及以下的儿童中,9名镇静失败(成功率96%);在97名48个月以上的儿童中,18名镇静失败(成功率81%)。单尾t检验显示,镇静失败的儿童显著比成功的儿童年龄大,具有0.0005的显著性水平。48个月以上儿童的失败率稳步上升。一些失败也可能是由于检查时间过长导致的。水合氯醛镇静的不良反应包括多动(6%)、呕吐(4%)和轻度呼吸抑制(4%)。没有不良反应严重到需要住院治疗。
48个月以上儿童水合氯醛镇静的较高失败率表明,患者年龄是水合氯醛镇静对接受MR成像儿童有效性的一个重要限制因素。然而,不良反应发生率低使得水合氯醛成为接受MR成像儿童镇静的一种安全药物。